Journal
BIOCHIMIE
Volume 182, Issue -, Pages 73-84Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biochi.2020.12.022
Keywords
Alcoholic liver disease; Fibrosis; Pig cancer model; Translational research; Matrix metalloproteinases
Categories
Funding
- United States Department of Defense (Translational Team Science Award) [CA150590]
- Guerbet USA LLC (Healthcare Professional Grant for ethiodized oil material transfer)
- Illinois Health Disparities Initiative
- University of Illinois Department of Radiology
- National Institutes of Health, Office of the Director [K01ODO22982]
- National Center for Advancing Translational Sciences [L30 TR002126]
Ask authors/readers for more resources
Hepatocellular carcinoma (HCC) is the 5th most common and 2nd deadliest cancer worldwide, with alcohol induced liver cirrhosis being a critical risk factor. Research using the Oncopig cancer model demonstrates that it recapitulates the transcriptional hallmarks of human cirrhosis, making it an ideal model for studying the effects of the cirrhotic liver microenvironment on HCC tumor biology and therapeutic responses.
Hepatocellular carcinoma (HCC) is the 5th most common and 2nd deadliest cancer worldwide. HCC risk factors include alcohol induced liver cirrhosis, which prompts hepatic inflammation, cell necrosis, and fibrosis deposition. As 25% of HCC cases are associated with alcohol induced liver disease, understanding the effects of the cirrhotic liver microenvironment on HCC tumor biology and therapeutic responses are critical. This study utilized the Oncopig Cancer Model-a transgenic pig model that recapitulates human HCC through induced expression of KRAS(G12D) and TP53(R167H )driver mutations-to investigate the molecular mechanisms underlying alcohol induced liver disease. Oncopigs (n = 5) underwent fibrosis induction via infusion of ethanol and ethiodized oil (1:3 v/v dosed at 0.75 mL/kg) into the hepatic arterial circulation. Eight-weeks post induction, liver tissue samples from fibrotic and age-matched control (n = 5) Oncopigs were collected for histological evaluation and transcriptional profiling. Increased hepatic inflammation and fibrosis was observed in fibrotic Oncopigs via pathological assessment. Transcriptional profiling (RNA-seq) resulted in the identification of 4387 differentially expressed genes between Oncopig fibrotic and control livers. GO term enrichment analysis identified pathway alterations associated with cirrhosis progression in humans, including cell proliferation, angiogenesis, extracellular matrix deposition, and oxidation-reduction. Key alterations include activation of hepatic stellate cells, increased matrix metalloproteinase production, and altered expression of ABC and SLC transporter genes involved in transport of anticancer drugs.These results demonstrate Oncopig liver fibrosis recapitulates transcriptional hallmarks of human cirrhosis, making the Oncopig an ideal model for studying the effects of the cirrhotic liver microenvironment on HCC tumor biology and therapeutic response. (C) 2021 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available